Target intelligence / Profile preview

Tyrosine kinase non-receptor 2 (ACK1)

Target
ACK1
Molecular classification
Enzyme, Non-receptor tyrosine kinase, Protein kinase
01

Overview

Tyrosine kinase non-receptor 2 (ACK1) is a cytoplasmic enzyme belonging to the Ack family of protein kinases. It functions as a non-receptor tyrosine-protein kinase that plays key roles in regulating cellular processes such as growth, proliferation, differentiation, adhesion, migration and apoptosis. Like other members of its class, aberrant activity due to mutation or overexpression has been linked with cancer development—including tumor progression and metastasis—making it an attractive therapeutic target for small-molecule inhibitors designed to disrupt oncogenic signaling pathways. The human gene encoding this protein is TNK2 located at chromosome 3q29. Common aliases include activated Cdc42-associated kinase 1 (ACK1) and Pyk1.

Other names
Activated Cdc42-associated kinase 1ACK1Pyk1TNK2 (gene symbol)Tyrosine kinase, non-receptor, 2
02

Mechanism of action

Drugs or inhibitors targeting this molecule would typically act by inhibiting its ATP-binding site or catalytic activity to block downstream signaling pathways involved in cell proliferation and survival. This is analogous to other tyrosine kinases where inhibition prevents phosphorylation events necessary for signal transduction.

03

Biological functions

Signal transductionCell growth regulationCell proliferation and differentiationCell migration and adhesionApoptosis
04

Disease associations

Cancer (including tumor progression, metastasis, drug resistance)
05

Safety considerations

Notable safety concerns with inhibition of non-receptor tyrosine kinases can include off-target effects on normal cell signaling leading to immune suppression or cytopenias; however, no specific safety issues unique to ACK1/TNK2 are detailed here.
06

Interacting drugs

No specific drugs are listed in the provided results as directly targeting Tyrosine kinase non-receptor 2 (ACK1/TNK2). However, as a member of the tyrosine kinase family implicated in cancer biology, it is a potential target for small molecule tyrosine kinase inhibitors. Some research compounds and investigational agents may exist but are not named here.
07

Biomarkers

No specific biomarkers for patient selection or efficacy monitoring related to ACK1/TNK2 are mentioned in the provided results.

Beyond the preview

Go deeper on Tyrosine kinase non-receptor 2 (ACK1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tyrosine kinase non-receptor 2 (ACK1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call